Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S De Wit

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Clinical Pharmacokinetics|February 4, 2015
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical EvidenceJacqueline S L Kloth, Lisette Binkhorst, Annelieke S de Wit, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
International Journal of Cardiology|March 11, 2025
Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failureC L Palm, S de Wit, T M Gorter, et al.
European Journal of Clinical Nutrition|June 3, 2010
European micronutrient recommendations aligned: a general framework developed by EURRECAR A M Dhonukshe-Rutten, L Timotijevic, A E J M Cavelaars, et al.
HIV Medicine|July 30, 2015
Late presentation to HIV testing is overestimated when based on the consensus definitionA Sasse, E Florence, A Pharris, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
Cardio-Oncology (London, England)|August 5, 2024
Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHFP F van den Berg, L I Yousif, G Markousis-Mavrogenis, et al.
Nature Communications|October 27, 2019
DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant bufferingChiara Milanese, Cíntia R Bombardieri, Sara Sepe, et al.
Breast Cancer Research and Treatment|June 8, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patientsLisette Binkhorst, Jacqueline S L Kloth, Annelieke S de Wit, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Clinical Pharmacokinetics|February 4, 2015
Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical EvidenceJacqueline S L Kloth, Lisette Binkhorst, Annelieke S de Wit, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
International Journal of Cardiology|March 11, 2025
Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failureC L Palm, S de Wit, T M Gorter, et al.
European Journal of Clinical Nutrition|June 3, 2010
European micronutrient recommendations aligned: a general framework developed by EURRECAR A M Dhonukshe-Rutten, L Timotijevic, A E J M Cavelaars, et al.
HIV Medicine|July 30, 2015
Late presentation to HIV testing is overestimated when based on the consensus definitionA Sasse, E Florence, A Pharris, et al.
HIV Medicine|February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in EuropeJ R Santos, A Cozzi-Lepri, A Phillips, et al.
Cardio-Oncology (London, England)|August 5, 2024
Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHFP F van den Berg, L I Yousif, G Markousis-Mavrogenis, et al.
Nature Communications|October 27, 2019
DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant bufferingChiara Milanese, Cíntia R Bombardieri, Sara Sepe, et al.
Breast Cancer Research and Treatment|June 8, 2015
Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patientsLisette Binkhorst, Jacqueline S L Kloth, Annelieke S de Wit, et al.
Pageof 15